Results 141 to 150 of about 57,654 (328)
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy
Transplant Infectious Disease, EarlyView.ABSTRACT Vaccine adjuvants are essential for enhancing immune responses to vaccines, particularly in immunocompromised populations who typically demonstrate suboptimal responses to standard vaccination. This narrative review evaluates the safety and efficacy of approved and candidate adjuvants in immunocompromised hosts, with emphasis on solid organ ...
Haya Hayek +8 more
wiley +1 more source
Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]
, 2011 Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC +4 more
core +1 more source
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
American Journal of Hematology, Volume 100, Issue S4, Page 30-50, June 2025.ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source
American Journal of Epidemiology, 2019 The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without pre-specifying the specific events or post-exposure risk intervals of concern.
W. K. Yih +3 more
semanticscholar +1 more source
Protocol to Increase Administration of Herpes Zoster Vaccine in a Long-Term Care Facility [PDF]
, 2016 Although the herpes zoster (HZ) vaccine to decrease the incidence of Shingles was licensed for use in 2008, little coverage for HZ vaccination has occurred and stands nationally at 16%.
Mbola, Stephen, DNP, RN, ANP-BC
core
BMJ Public HealthBackground Studies report herpes zoster associated with short-term stroke risk, but it is unclear whether herpes zoster vaccine reduces stroke risk.Methods We performed cohort studies using Clinical Practice Research Datalink Aurum linked to hospital ...
Fawziah Marra +4 more
doaj +1 more source
Vacunación frente al virus del herpes zóster
Atención Primaria, 2023 Resumen: Objetivo: Revisar las últimas evidencias publicadas respecto a la vacuna utilizada en nuestro país frente al virus del herpes zóster, desglosadas por eficacia, eficiencia, efectividad y seguridad vacunal.
José Javier Gómez Marco +4 more
doaj
A New Vaccine to Prevent Herpes Zoster [PDF]
New England Journal of Medicine, 2015 Among persons who live until the age of 85 years, herpes zoster will develop in approximately half, with an incidence that seems to be increasing. Although the disease may be mild in healthy young adults, persons over the age of 50 years and those who are immunocompromised are more likely to have complications that include herpes zoster ophthalmicus ...
openaire +3 more sources
Vaccination dilemma on an evolving social network [PDF]
arXiv, 2019 Vaccination is crucial for the control of epidemics. Yet it is a social dilemma since non-vaccinators can benefit from the herd immunity created by the vaccinators. Thus the optimum vaccination level is not reached via voluntary vaccination at times.
arxiv
Monoclonal B‐Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect
Hematological Oncology, Volume 43, Issue S2, June 2025.ABSTRACT Monoclonal B‐cell lymphocytosis (MBL) is a hematologic condition defined by the presence of a small clonal B‐cell population in the peripheral blood, without clinical or laboratory evidence of lymphoproliferative disorders. It is classified into low‐count (LC‐MBL) and high‐count (HC‐MBL) subtypes based on clonal size. HC‐MBL shares genetic and
Andrea Serafin +6 more
wiley +1 more source